Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors
International Journal of Molecular Sciences（2023）
Key words
multiple myeloma,PD-1,CTLA-4,immune checkpoint inhibitors,time to progression,clinical response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined